Aceto (ACET) Rating Reiterated by Canaccord Genuity
A number of other equities research analysts also recently commented on ACET. ValuEngine downgraded shares of Aceto from a buy rating to a hold rating in a research report on Friday, February 2nd. BidaskClub upgraded shares of Aceto from a strong sell rating to a sell rating in a research report on Thursday, January 4th. Finally, Zacks Investment Research upgraded shares of Aceto from a strong sell rating to a hold rating in a research report on Monday, October 30th.
Aceto (NASDAQ:ACET) opened at $7.26 on Monday. The company has a current ratio of 2.00, a quick ratio of 1.38 and a debt-to-equity ratio of 0.79. Aceto has a twelve month low of $7.20 and a twelve month high of $17.10. The stock has a market capitalization of $237.49, a PE ratio of -47.44, a P/E/G ratio of 0.76 and a beta of 1.40.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 23rd. Investors of record on Friday, March 9th will be given a $0.065 dividend. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $0.26 dividend on an annualized basis and a yield of 3.58%. Aceto’s payout ratio is currently -162.50%.
A number of large investors have recently made changes to their positions in ACET. SG Americas Securities LLC acquired a new stake in Aceto in the third quarter valued at about $106,000. Teacher Retirement System of Texas acquired a new stake in shares of Aceto during the 4th quarter valued at approximately $108,000. Palisade Capital Management LLC NJ acquired a new stake in shares of Aceto during the 3rd quarter valued at approximately $131,000. BNP Paribas Arbitrage SA lifted its position in shares of Aceto by 73.4% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 14,924 shares of the company’s stock valued at $168,000 after acquiring an additional 6,316 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC acquired a new stake in shares of Aceto during the 3rd quarter valued at approximately $190,000. Hedge funds and other institutional investors own 78.41% of the company’s stock.
Aceto Company Profile
Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products.
Receive News & Ratings for Aceto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aceto and related companies with MarketBeat.com's FREE daily email newsletter.